# OnCo record inflammatory-breast-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/inflammatory-breast-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "inflammatory-breast-cancer" ;
  schema:name "Inflammatory breast cancer"@en ;
  schema:alternateName "IBC"@en, "T4d breast cancer"@en, "Inflammatory carcinoma of the breast"@en ;
  schema:description "Inflammatory breast cancer does not usually form a lump. The breast becomes red, swollen, warm and heavy over weeks, with skin thickened like orange peel, because cancer cells have blocked the lymph channels in the skin. It is often mistaken for infection, is always at least stage III, and needs chemotherapy first, then mastectomy and radiotherapy, with HER2 or immune drugs added by subtype."@en ;
  schema:url <https://onco.cc/cancers/inflammatory-breast-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Inflammatory_breast_cancer> ;
  schema:citation <https://www.cancer.gov/types/breast/ibc-fact-sheet>, <https://doi.org/10.1093/annonc/mdq345>, <https://en.wikipedia.org/wiki/Inflammatory_breast_cancer> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:people <https://onco.cc/people/naoto-ueno/>, <https://onco.cc/people/massimo-cristofanilli/>, <https://onco.cc/people/gabriel-hortobagyi/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-trial-diversity/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/sacituzumab-govitecan/>, <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:standardOfCare <https://onco.cc/terms/core-needle-biopsy/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/mammography/>, <https://onco.cc/technologies/ultrasound/>, <https://onco.cc/technologies/pet/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/pertuzumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/trials/keynote-522/>, <https://onco.cc/terms/mastectomy/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/tamoxifen/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/trastuzumab-emtansine/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/trials/katherine/>, <https://onco.cc/trials/destiny-breast05/>, <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/trials/olympia/> .